Suppr超能文献

全外显子组测序可鉴定突尼斯的两个新型着色性干皮病(XP)群体,XP-D 和 XP-E:对分子诊断的影响。

Whole Exome Sequencing allows the identification of two novel groups of Xeroderma pigmentosum in Tunisia, XP-D and XP-E: Impact on molecular diagnosis.

机构信息

Laboratory of Biomedical Genomics and Oncogenetics (LR11IPT05), Institut Pasteur de Tunis, Université Tunis El Manar, El Manar I, 2092 Tunis, Tunisia.

Laboratory of Biomedical Genomics and Oncogenetics (LR11IPT05), Institut Pasteur de Tunis, Université Tunis El Manar, El Manar I, 2092 Tunis, Tunisia.

出版信息

J Dermatol Sci. 2018 Feb;89(2):172-180. doi: 10.1016/j.jdermsci.2017.10.015. Epub 2017 Nov 2.

Abstract

BACKGROUND

Skin cancers (SC) are complex diseases that develop from complex combinations of genetic and environmental risk factors. One of the most severe and rare genetic diseases predisposing to SC is the Xeroderma pigmentosum (XP) syndrome.

OBJECTIVES

First, to identify the genetic etiology of XP and to better classify affected patients. Second, to provide early molecular diagnosis for pre-symptomatic patient and finally to offer genetic counseling for related individuals.

METHODS

Whole Exome Sequencing (WES) and Run Of Homozygosity (ROH) were performed for two patients belonging to two different multiplex consanguineous families. The identified mutations were confirmed by Sanger sequencing and researched in ten Tunisian families including a total of 25 affected individuals previously suspected as having XP group V (XP-V) form. All patients had mild dermatological manifestations, absence of neurological abnormalities and late onset of skin tumors.

RESULTS

Screening for functional variations showed the presence of the ERCC2 p.Arg683Gln in XP14KA-2 patient and a novel mutation, DDB2 p. (Lys381Argfs*2), in XP51-MAH-1 patient. Sanger sequencing and familial segregation showed that the ERCC2 mutation is present at a homozygous state in 10 affected patients belonging to 3 families. The second mutation in DDB2, is present at a homozygous state in 5 affected cases belonging to the same family. These two mutations are absent in the remaining 10 affected patients. The ERCC2 c.2048G > A mutation is present in a medium ROH region (class B) suggesting that it mostly arises from ancient relatedness within individuals. However, the c.1138delG DDB2 mutation is present in a large ROH region (class C) suggesting that it arises from recent relatedness.

CONCLUSION

To our knowledge, this is the first study that identifies XP-D and XP-E complementation groups in Tunisia. These two groups are very rare and under-diagnosed in the world and were not reported in North Africa.

摘要

背景

皮肤癌(SC)是一种复杂的疾病,由遗传和环境风险因素的复杂组合发展而来。导致 SC 的最严重和罕见的遗传性疾病之一是着色性干皮病(XP)综合征。

目的

首先,确定 XP 的遗传病因,更好地对受影响的患者进行分类。其次,为有症状前患者提供早期分子诊断,最后为相关个体提供遗传咨询。

方法

对属于两个不同多重近亲家庭的两名患者进行全外显子组测序(WES)和纯合区 RUN(ROH)分析。通过 Sanger 测序确认鉴定的突变,并在包括先前疑似 XP 组 V(XP-V)形式的 25 名受影响个体在内的 10 个突尼斯家庭中进行研究。所有患者均有轻度皮肤表现,无神经异常,皮肤肿瘤发病较晚。

结果

对功能变异的筛查显示,XP14KA-2 患者存在 ERCC2 p.Arg683Gln 突变,XP51-MAH-1 患者存在新的突变 DDB2 p.(Lys381Argfs*2)。Sanger 测序和家族分离显示,在属于 3 个家庭的 10 名受影响患者中,ERCC2 突变呈纯合状态。DDB2 中的第二个突变在属于同一家庭的 5 名受影响病例中呈纯合状态。其余 10 名受影响患者中不存在这两种突变。ERCC2 c.2048G > A 突变存在于中等 ROH 区域(B 类),表明它主要源自个体内部的古老亲缘关系。然而,c.1138delG DDB2 突变存在于较大的 ROH 区域(C 类),表明它源自最近的亲缘关系。

结论

据我们所知,这是在突尼斯首次确定 XP-D 和 XP-E 互补组的研究。这两个组在世界上非常罕见且诊断不足,在北非也没有报道。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验